Dr. Jonathan Patrick Grady, MD

Dr. Grady practices at Brazosport Eye Institute Surgery Center in Lake Jackson, Texas.

Dr. Grady's NPI, 1386838563, was assigned on August 30, 2007. Dr. Grady graduated from UTMB Health in 2007. Dr. Grady's Texas license number on file is P1645.

Dr. Grady's primary practice is Brazosport Eye Institute Surgery Center, at 103 Parking Way, Lake Jackson, TX 77566. The practice phone is (979) 297-2961.

Dr. Grady's primary practice is Brazosport Eye Institute Surgery Center in Lake Jackson, Texas. Dmand AI also links Dr. Grady to 1 medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grady practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Grady's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Grady is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Grady's licenses on file in 2 states: Texas and Michigan.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, eye infection or inflammation, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Grady treats.

CMS data shows 2,287 Medicare services from Dr. Grady across 19 procedure codes in 2024, for 456 Medicare patients. Medicare paid $149,519 for them.

CMS counts 456 Medicare patients who saw Dr. Grady in 2024. The largest group is 65 to 74, with 222 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Grady's median patient age at 73, with 57% women.

In 2024, Dr. Grady wrote 2,555 Medicare Part D claims for 582 patients. 38% of them were for generic drugs. CMS names the drug for 2,439 of them, across 35 drugs with 11 or more claims each, at $907,355 in total drug cost. In 2023, CMS named 2,312 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Grady for performance year 2024, reported individually. Dr. Grady accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 128 procedures of cataract surgery by Dr. Grady, more than 78% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Grady to 1 clinical trial. Conditions studied include Hyperemia and Keratoconjunctivitis Sicca.

CMS Open Payments shows 633 general payments to Dr. Grady from 37 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 75% of the total. Abbvie Inc. paid the most, $204,986.

Dr. Grady graduated from UTMB Health in 2007.

Dr. Grady is in network with 22 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.